Last edition
News about "respiratory diseases "
Sanofi's Lunsekimig Shows Promising Phase II Results in Asthma and Nasal Polyps Studies
The novel dual-targeting Nanobody met primary and key secondary endpoints in asthma and chronic rhinosinusitis trials, demonstrating improved outcomes and a favourable safety profile.
Respiratory Diseases | 08/04/2026 | By News Bureau
Moderna Opens mRNA Vaccine Manufacturing Facility in the UK
The Moderna Innovation and Technology Centre (MITC) has officially opened at the Harwell Science and Innovation Campus in Oxfordshire, becoming the UK’s first facility to manufacture an onshore supply of mRNA vaccines.
Respiratory Diseases | 25/09/2025 | By Dineshwori | 122
Lupin Acquires Two Brands from Sanofi in Europe and Canada
Lupin has announced that its European hub entity, Lupin Atlantis Holdings SA, has completed the acquisition of two well-known brands, Aarane in Germany and Nalcrom in Canada and the Netherlands, along with the associated trademark rights, from Sanofi.
Respiratory Diseases | 10/06/2024 | By Aishwarya | 1470
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy